Be Clinical, an evidence-led skincare brand focused on clinically effective solutions for ageing skin, has raised INR 21 Crore in its Seed round, led by Sauce. The round also saw participation from V3 Ventures (Verlinvest SA) and a group of angel investors, including Mokobara founders Sangeet Agrawal and Navin Parwal; Arjun Purkayastha, SVP & Managing Director for Greater China & North Asia at Reckitt; and Shaunak Chirayu Amin. Founded by Hemangi Dhir and launched in May 2025 after two years of research and development, Be Clinical is building a skincare brand built around clinically tested formulations, dermatologically active ingredients and an evidence-led approach to addressing ageing concerns. The brand’s products are developed specifically with Indian skin and conditions in mind, with clinical testing undertaken to validate safety and efficacy before products reach consumers. The brand, through its in-house manufacturing, occupies control over the quality and efficacy of its products. The brand has recorded significant momentum since its launch, having delivered 1.2 lakh orders and seen good repeats. The early traction reflects growing consumer interest in skincare solutions that combine active ingredients with clinical validation and a focus on measurable results. The funds raised will be used to support Be Clinical’s next phase of growth, with a focus on product innovation and portfolio expansion. The capital will strengthen research and development capabilities, expand the clinical skincare range, scale manufacturing capacity to meet growing demand, and support expansion into new markets and geographies. The company’s focus will remain on developing clinically tested, transparent and effective skincare solutions that address ageing concerns, while making science-backed skincare more accessible to Indian consumers. The latest round also reflects continued confidence from existing investors in Be Clinical’s growth trajectory and long-term potential.
